Research Pipeline: New Migraine Therapies in Development

You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!


Key Questions
  • What new preventatives are in development?
  • What new acute therapies are in development?
  • When can we expect a cure?
Interview Notes
Deborah Friedman

Deborah Friedman, MD, MPH, FAAN

Professor of Neurology & Ophthalmology
UT Southwestern

Deborah I. Friedman, M.D., M.P.H., is a professor in the department of neurology and the department of ophthalmology at the UT Southwestern Medical Center. A neuro-ophthalmologist, Dr. Friedman is chief of the division of headache medicine, and the founding director of UT Southwestern’s Headache and Facial Pain Program.  Dr. Friedman is board certified in neurology, with subspecialty certification in headache medicine by the United Council for Neurologic Subspecialties.  Dr. Friedman is a fellow of the American Academy of Neurology, the American Headache Society, and the North American Neuro-Ophthalmology Society.

Get your own copy of the entire Summit

  • 30+ Expert interviews with audio clips and transcripts
  • Unlimited streaming and downloads
  • Lifetime access with no annual fee
Access Pass options

Related Talks for: Day 6 (2017)

Best Acute Treatments You May Not Have Tried

Lawrence C. Newman, MD

Managing Migraine Emergencies: Avoiding the ER

Richard Lipton, MD

Behavioural Treatments for Migraine

Paul R. Martin, PhD

Neuromodulation: New Devices That Can Ease Pain

Brian Grosberg, MD

You’re Not Alone: What People Don’t Get About Migraine

Lisa Jacobson

Leave a comment


Back to top

Loading...